NVST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally...

Stats
Today's Volume	1.17M
Average Volume	2.43M
Market Cap	3.49B
EPS	$0 ( 2024-02-07 )
Next earnings date	( $0.320 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-33.80
ATR14	$0.0120 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Hulit Barbara B.	Buy	13 065	Common Stock
2024-03-15	Hulit Barbara B.	Buy	11 705	Common Stock
2024-02-25	Kaabi Faez C	Buy	30 915	Common Stock
2024-02-25	Kaabi Faez C	Buy	20 620	Employee Stock Option (Right to Buy)
2024-02-25	Kaabi Faez C	Sell	1 505	Common Stock

INSIDER POWER
63.72
Last 100 transactions
Buy: 889 684 \| Sell: 239 403

Volume Correlation

Long: 0.46 (neutral)

Short: -0.14 (neutral)

Signal:(69.699) Neutral

Envista Holdings Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Envista Holdings Corp Correlation - Currency/Commodity

0.69
( moderate )

0.88
( strong )

0.00
( neutral )

-0.55
( weak negative )

-0.38
( neutral )

0.59
( weak )

Envista Holdings Corp Financials

Annual	2023
Revenue:	$2.57B
Gross Profit:	$1.44B (56.13 %)
EPS:	$-0.600

Q4	2023
Revenue:	$645.60M
Gross Profit:	$335.90M (52.03 %)
EPS:	$-1.270

Q3	2023
Revenue:	$631.30M
Gross Profit:	$363.30M (57.55 %)
EPS:	$0.130

Q2	2023
Revenue:	$662.40M
Gross Profit:	$378.60M (57.16 %)
EPS:	$0.320

Financial Reports:

No articles found.

Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.